Fig. 2

Kaplan‒Meier postoperative survival curves. Postoperative survival was significantly longer in patients with castration-sensitive prostate cancer, 33 (IQR 15–55) months, than in patients with castration-resistant prostate cancer (CRPC), 8 (IQR 4–18) months, (p < 0.001).